More Videos
SPECIAL REPORT
MOST SHARED
- Tiger Woods Out of Hospital After Accident
- The Good Entrepreneur Winner
- Get Paid Six Figures to Wear a T-Shirt?
- Dubai Spooks Investors But May Bring Buying Opportunity
- Global Selloff From Dubai Woes Shows Signs of Winding Down
- Longer Lines, Fuller Carts This Black Friday
- Halftime Report: Dubai - First Ripple Of Larger Crisis?
- 8 Retailers that Gain During the Holidays
- U.S. Stocks Fall on Dubai Worries
- Black Friday at Best Buy
- Strategists on Dubai: Avoid 'Rash Moves' Now
- Longer Lines, Fuller Carts This Black Friday
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Obama's Emission Reduction Pledge Paints Future for Autos
- Is Super Bowl Halftime Act Too Old?
- Surprising Options Trades in TiVo Shares
- EA Sports Hopes to Pump Up Sales Through Pop-Up Locations
- Global Selloff From Dubai Shows Signs of Winding Down
- Dubai Stock Selloff May Bring Buying Opportunity
- Longer Lines, Fuller Carts This Black Friday
- Tiger Woods Out of Hospital After Accident
- Dubai Fallout Is a Correction, Not Another Crisis: El-Erian
- Dubai's Debt Woes Signal New Era for Creditors
- Get Paid Six Figures to Wear a T-Shirt?
- The World's Biggest Debtor Nations
- Five Tips for Buying a Foreclosed Home
PHARMA'S MARKET VIDEO
RSS FEED
Pharma's Market
Text Size 
Only on a day like today when it's wall-to-wall Madoff coverage would a $47 billion deal, the second $40-billion-plus deal to be done in four days, struggle to get some airtime. So, what would normally get prominent placement at various times throughout the day on CNBC-TV, can be heard in its entirety here at "Pharma's Market."
This morning, Roche Chairman Franz Humer, purportedly the driving force behind the hostile takeover of DNA [DNA
Loading...
()
], gave me an exclusive recorded phone interview. I was able to get a quickie soundbite from it on "Power Lunch" where Humer said he doesn't have any hatchets to bury with Genentech Chairman and CEO Art Levinson and his team.
He said the acrimony between the two sides was "just business."
I thought the folks who work at Genentech—and maybe even those who work for Roche—might want to hear everything Mr. Humer had to say, so here's the entire approximately seven-and-a-half minute conversation.
A Genentech spokesman said its execs aren't doing any news media interviews. Art—since now I know that you read the blog—anytime, anywhere.
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes